Form 4: Precigen Director Jeffrey B. Kindler Acquires Shares and Stock Units in Lieu of Retainer
SEC Form 4 Filing
Director Jeffrey B. Kindler acquired shares and restricted stock units of Precigen, Inc. in lieu of an annual retainer.
Summary
- On March 14, 2024, Jeffrey B. Kindler, a director of Precigen, Inc., acquired 48,251 shares of common stock at a price of $1.43 per share.
- These shares were issued in lieu of an annual retainer of $68,999.
- Kindler also acquired 87,412 restricted stock units (RSUs), each representing a contingent right to receive one share of Precigen common stock, which vest in full on March 14, 2025.
- Additionally, Kindler acquired an option to purchase 101,626 shares of common stock at an exercise price of $1.43, expiring on March 14, 2034.
- Following these transactions, Kindler beneficially owns 393,363 shares of Precigen common stock, 87,412 restricted stock units, and options to purchase 101,626 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects a routine transaction by a director, with no explicit positive or negative implications for the company's overall performance.
Positives
- Director's acquisition of shares and stock units may signal confidence in the company's future prospects.
- The acceptance of shares in lieu of cash retainer could be seen as a positive sign of commitment to the company's long-term success.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be indicative of their confidence in the company's performance.
Related Party Transactions
- The issuance of shares and RSUs to Jeffrey B. Kindler in lieu of an annual retainer constitutes a related party transaction.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of director confidence.
- The issuance of shares may slightly dilute existing shareholders' equity.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction: acquisition of common stock, restricted stock units, and stock options. |
| 03/14/2025 | Vesting date for the 87,412 restricted stock units. |
| 03/14/2034 | Expiration date for the option to purchase 101,626 shares of common stock. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.